id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-103829-mavc34a0	Alam, T.	Extended effect of short-course azithromycin for the treatment of diarrhoea in children on antimicrobial resistance in nasopharyngeal and intestinal bacteria: Study Protocol for the antimicrobial resistance sub-study of the multicountry AntiBiotics for Children with Diarrhea (ABCD) trial.	2020-07-19		.txt	text/plain	5156	257	49	We aim to determine the impact of a 3-day course of azithromycin on the risk of AMR at 90 and 180 days after treatment, among a subset of children and their household contacts enrolled into a multi-country, randomized, double-blind, placebo-controlled clinical trial of azithromycin children under 2 years with diarrhea in low income settings, Methods and analysis The AntiBiotics for Children with Diarrhea (ABCD) trial is testing the efficacy of a 3-day course of azithromycin, compared to placebo, in reducing mortality and linear growth faltering in the subsequent 6 months among 11,500 children aged 2-23 months of age across multiple sites in Bangladesh, India, Kenya Malawi, Mali, Pakistan and Tanzania with diarrhea and one or more of the following; dehydration, severe stunting, or moderate wasting (https://clinicaltrials.gov/ct2/show/NCT03130114). pneumoniae, isolated from nasopharyngeal swabs, is no different between children treated with 3-days of azithromycin or placebo in a randomly selected sub-sample of children enrolled in the ABCD trial, at 90 and 180 days after treatment.	./cache/cord-103829-mavc34a0.txt	./txt/cord-103829-mavc34a0.txt